Scilex Holding Company Operating Lease, Liability, Noncurrent
Scilex Holding Company (SCLX) had Operating Lease, Liability, Noncurrent of $12.51 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Noncurrent $12.51M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $12.69M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $13.15M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $918.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $12.51M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $12.69M 10-Q · filed 2026-05-20 |
| 2025-12-31 | $13.15M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $918.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.13M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.33M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.52M 10-K · filed 2026-04-10 |
| 2024-09-30 | $1.71M 10-Q · filed 2025-01-17 |
| 2024-06-30 | $1.89M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $2.07M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $2.24M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.40M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.59M 10-Q · filed 2023-08-11 |
| 2023-04-30 | $2.50M 10-K · filed 2025-03-31 |
| 2023-03-31 | $461.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $665.00K 10-K · filed 2024-03-12 |
| 2021-12-31 | $1.15M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |